nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Lamivudine—hepatitis B	0.277	0.497	CbGbCtD
Ezetimibe—ABCC2—Lamivudine—hepatitis B	0.126	0.226	CbGbCtD
Ezetimibe—ABCG2—Lamivudine—hepatitis B	0.114	0.204	CbGbCtD
Ezetimibe—ABCB1—Lamivudine—hepatitis B	0.0411	0.0736	CbGbCtD
Ezetimibe—ABCG5—blood plasma—hepatitis B	0.0216	0.154	CbGeAlD
Ezetimibe—ABCG8—blood plasma—hepatitis B	0.0193	0.137	CbGeAlD
Ezetimibe—ABCC3—bile duct—hepatitis B	0.0152	0.108	CbGeAlD
Ezetimibe—ABCC2—bile duct—hepatitis B	0.0122	0.0865	CbGeAlD
Ezetimibe—ANPEP—Glutathione metabolism—GGT2—hepatitis B	0.00756	0.113	CbGpPWpGaD
Ezetimibe—NPC1L1—blood—hepatitis B	0.00746	0.053	CbGeAlD
Ezetimibe—ABCG8—blood—hepatitis B	0.00707	0.0503	CbGeAlD
Ezetimibe—ABCG5—liver—hepatitis B	0.0062	0.0441	CbGeAlD
Ezetimibe—NPC1L1—liver—hepatitis B	0.00583	0.0415	CbGeAlD
Ezetimibe—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.00564	0.0242	CcSEcCtD
Ezetimibe—ABCG8—liver—hepatitis B	0.00553	0.0393	CbGeAlD
Ezetimibe—Transaminases increased—Entecavir—hepatitis B	0.00539	0.0232	CcSEcCtD
Ezetimibe—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.00512	0.022	CcSEcCtD
Ezetimibe—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00469	0.0202	CcSEcCtD
Ezetimibe—Myopathy—Adefovir Dipivoxil—hepatitis B	0.00456	0.0196	CcSEcCtD
Ezetimibe—UGT1A1—blood plasma—hepatitis B	0.00421	0.0299	CbGeAlD
Ezetimibe—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00391	0.0168	CcSEcCtD
Ezetimibe—Myopathy—Telbivudine—hepatitis B	0.00384	0.0165	CcSEcCtD
Ezetimibe—ANPEP—Glutathione metabolism—GGT1—hepatitis B	0.00358	0.0532	CbGpPWpGaD
Ezetimibe—SLCO1B1—blood plasma—hepatitis B	0.0035	0.0249	CbGeAlD
Ezetimibe—ABCC3—blood plasma—hepatitis B	0.00332	0.0236	CbGeAlD
Ezetimibe—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.0032	0.0137	CcSEcCtD
Ezetimibe—Rhabdomyolysis—Telbivudine—hepatitis B	0.00304	0.0131	CcSEcCtD
Ezetimibe—UGT2B15—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00299	0.0444	CbGpPWpGaD
Ezetimibe—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00289	0.0124	CcSEcCtD
Ezetimibe—Neck pain—Telbivudine—hepatitis B	0.00273	0.0117	CcSEcCtD
Ezetimibe—Hepatic failure—Entecavir—hepatitis B	0.00265	0.0114	CcSEcCtD
Ezetimibe—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00258	0.0111	CcSEcCtD
Ezetimibe—SOAT1—blood—hepatitis B	0.00255	0.0182	CbGeAlD
Ezetimibe—UGT1A3—liver—hepatitis B	0.00247	0.0176	CbGeAlD
Ezetimibe—ANPEP—blood—hepatitis B	0.00244	0.0174	CbGeAlD
Ezetimibe—UGT2B15—liver—hepatitis B	0.00232	0.0165	CbGeAlD
Ezetimibe—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00221	0.00948	CcSEcCtD
Ezetimibe—Myopathy—Lamivudine—hepatitis B	0.00216	0.0093	CcSEcCtD
Ezetimibe—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00214	0.00921	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00205	0.0088	CcSEcCtD
Ezetimibe—Pancreatitis—Entecavir—hepatitis B	0.00202	0.00867	CcSEcCtD
Ezetimibe—SOAT1—liver—hepatitis B	0.002	0.0142	CbGeAlD
Ezetimibe—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00197	0.00846	CcSEcCtD
Ezetimibe—Pain in extremity—Telbivudine—hepatitis B	0.00195	0.0084	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Entecavir—hepatitis B	0.00191	0.00822	CcSEcCtD
Ezetimibe—ANPEP—liver—hepatitis B	0.00191	0.0136	CbGeAlD
Ezetimibe—Cramp muscle—Telbivudine—hepatitis B	0.00176	0.00757	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00176	0.00757	CcSEcCtD
Ezetimibe—Nasopharyngitis—Telbivudine—hepatitis B	0.00175	0.00751	CcSEcCtD
Ezetimibe—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00174	0.0075	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Entecavir—hepatitis B	0.00173	0.00745	CcSEcCtD
Ezetimibe—Gastritis—Telbivudine—hepatitis B	0.00173	0.00744	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00172	0.00741	CcSEcCtD
Ezetimibe—Muscular weakness—Telbivudine—hepatitis B	0.00172	0.00741	CcSEcCtD
Ezetimibe—Rhabdomyolysis—Lamivudine—hepatitis B	0.00172	0.00737	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00169	0.00727	CcSEcCtD
Ezetimibe—Influenza—Telbivudine—hepatitis B	0.00169	0.00726	CcSEcCtD
Ezetimibe—Viral infection—Lamivudine—hepatitis B	0.00168	0.00722	CcSEcCtD
Ezetimibe—Bone disorder—Lamivudine—hepatitis B	0.00168	0.00722	CcSEcCtD
Ezetimibe—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00168	0.00721	CcSEcCtD
Ezetimibe—Hepatitis—Entecavir—hepatitis B	0.00165	0.00708	CcSEcCtD
Ezetimibe—Drug interaction—Lamivudine—hepatitis B	0.00164	0.00703	CcSEcCtD
Ezetimibe—Oedema peripheral—Entecavir—hepatitis B	0.00162	0.00697	CcSEcCtD
Ezetimibe—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00161	0.0069	CcSEcCtD
Ezetimibe—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00159	0.00685	CcSEcCtD
Ezetimibe—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00158	0.00678	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00157	0.00675	CcSEcCtD
Ezetimibe—UGT2B15—Phase II conjugation—GGT2—hepatitis B	0.00157	0.0233	CbGpPWpGaD
Ezetimibe—Inflammation—Lamivudine—hepatitis B	0.00156	0.00672	CcSEcCtD
Ezetimibe—Vasculitis—Lamivudine—hepatitis B	0.00156	0.00668	CcSEcCtD
Ezetimibe—UGT1A1—blood—hepatitis B	0.00154	0.011	CbGeAlD
Ezetimibe—Immune system disorder—Entecavir—hepatitis B	0.00149	0.00639	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Telbivudine—hepatitis B	0.00148	0.00635	CcSEcCtD
Ezetimibe—Alopecia—Entecavir—hepatitis B	0.00145	0.00625	CcSEcCtD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—ALB—hepatitis B	0.00145	0.0216	CbGpPWpGaD
Ezetimibe—Mental disorder—Entecavir—hepatitis B	0.00144	0.0062	CcSEcCtD
Ezetimibe—Malnutrition—Entecavir—hepatitis B	0.00143	0.00616	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Telbivudine—hepatitis B	0.00142	0.00612	CcSEcCtD
Ezetimibe—UGT2B7—liver—hepatitis B	0.00142	0.0101	CbGeAlD
Ezetimibe—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0014	0.00601	CcSEcCtD
Ezetimibe—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00138	0.00592	CcSEcCtD
Ezetimibe—UGT2B7—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00136	0.0202	CbGpPWpGaD
Ezetimibe—Back pain—Adefovir Dipivoxil—hepatitis B	0.00135	0.00581	CcSEcCtD
Ezetimibe—Hepatitis—Telbivudine—hepatitis B	0.00135	0.00581	CcSEcCtD
Ezetimibe—CYP3A4—blood plasma—hepatitis B	0.00135	0.0096	CbGeAlD
Ezetimibe—Pharyngitis—Telbivudine—hepatitis B	0.00134	0.00577	CcSEcCtD
Ezetimibe—Connective tissue disorder—Telbivudine—hepatitis B	0.00133	0.00571	CcSEcCtD
Ezetimibe—Flunarizine—CYP2A6—hepatitis B	0.0013	1	CrCbGaD
Ezetimibe—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00129	0.00555	CcSEcCtD
Ezetimibe—SLCO1B1—blood—hepatitis B	0.00128	0.00913	CbGeAlD
Ezetimibe—Cough—Adefovir Dipivoxil—hepatitis B	0.00122	0.00524	CcSEcCtD
Ezetimibe—Mediastinal disorder—Telbivudine—hepatitis B	0.00122	0.00524	CcSEcCtD
Ezetimibe—ABCC3—blood—hepatitis B	0.00122	0.00866	CbGeAlD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00121	0.00521	CcSEcCtD
Ezetimibe—UGT1A1—liver—hepatitis B	0.00121	0.00858	CbGeAlD
Ezetimibe—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00119	0.00512	CcSEcCtD
Ezetimibe—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00119	0.00512	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00118	0.00508	CcSEcCtD
Ezetimibe—Malnutrition—Telbivudine—hepatitis B	0.00118	0.00506	CcSEcCtD
Ezetimibe—Anaphylactic shock—Entecavir—hepatitis B	0.00117	0.00503	CcSEcCtD
Ezetimibe—Infection—Entecavir—hepatitis B	0.00116	0.00499	CcSEcCtD
Ezetimibe—Nervous system disorder—Entecavir—hepatitis B	0.00115	0.00493	CcSEcCtD
Ezetimibe—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00114	0.017	CbGpPWpGaD
Ezetimibe—Back pain—Telbivudine—hepatitis B	0.00114	0.00489	CcSEcCtD
Ezetimibe—Skin disorder—Entecavir—hepatitis B	0.00114	0.00488	CcSEcCtD
Ezetimibe—Muscle spasms—Telbivudine—hepatitis B	0.00113	0.00486	CcSEcCtD
Ezetimibe—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00112	0.00481	CcSEcCtD
Ezetimibe—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00112	0.0048	CcSEcCtD
Ezetimibe—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00111	0.00476	CcSEcCtD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—ALB—hepatitis B	0.0011	0.0164	CbGpPWpGaD
Ezetimibe—Ill-defined disorder—Telbivudine—hepatitis B	0.00109	0.00469	CcSEcCtD
Ezetimibe—Malaise—Telbivudine—hepatitis B	0.00106	0.00456	CcSEcCtD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—ALB—hepatitis B	0.00106	0.0158	CbGpPWpGaD
Ezetimibe—Insomnia—Entecavir—hepatitis B	0.00106	0.00455	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00104	0.00447	CcSEcCtD
Ezetimibe—Dyspepsia—Entecavir—hepatitis B	0.00103	0.00442	CcSEcCtD
Ezetimibe—Cough—Telbivudine—hepatitis B	0.00103	0.00442	CcSEcCtD
Ezetimibe—Liver function test abnormal—Lamivudine—hepatitis B	0.00102	0.00437	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Entecavir—hepatitis B	0.00101	0.00434	CcSEcCtD
Ezetimibe—Fatigue—Entecavir—hepatitis B	0.00101	0.00433	CcSEcCtD
Ezetimibe—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.001	0.00432	CcSEcCtD
Ezetimibe—SLCO1B1—liver—hepatitis B	0.001	0.00714	CbGeAlD
Ezetimibe—Arthralgia—Telbivudine—hepatitis B	0.001	0.00431	CcSEcCtD
Ezetimibe—Chest pain—Telbivudine—hepatitis B	0.001	0.00431	CcSEcCtD
Ezetimibe—Myalgia—Telbivudine—hepatitis B	0.001	0.00431	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000995	0.00428	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000992	0.00426	CcSEcCtD
Ezetimibe—Cramp muscle—Lamivudine—hepatitis B	0.000992	0.00426	CcSEcCtD
Ezetimibe—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000992	0.00426	CcSEcCtD
Ezetimibe—Discomfort—Telbivudine—hepatitis B	0.00099	0.00426	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000985	0.00423	CcSEcCtD
Ezetimibe—Nasopharyngitis—Lamivudine—hepatitis B	0.000985	0.00423	CcSEcCtD
Ezetimibe—ABCC2—blood—hepatitis B	0.000973	0.00692	CbGeAlD
Ezetimibe—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000972	0.00418	CcSEcCtD
Ezetimibe—Muscular weakness—Lamivudine—hepatitis B	0.000972	0.00418	CcSEcCtD
Ezetimibe—ABCC3—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000971	0.0144	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Entecavir—hepatitis B	0.000956	0.00411	CcSEcCtD
Ezetimibe—ABCB1—blood plasma—hepatitis B	0.000955	0.00679	CbGeAlD
Ezetimibe—Influenza—Lamivudine—hepatitis B	0.000952	0.00409	CcSEcCtD
Ezetimibe—ABCC3—liver—hepatitis B	0.000952	0.00677	CbGeAlD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000947	0.0141	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Telbivudine—hepatitis B	0.000942	0.00405	CcSEcCtD
Ezetimibe—Thrombocytopenia—Telbivudine—hepatitis B	0.000941	0.00404	CcSEcCtD
Ezetimibe—Pancreatitis—Lamivudine—hepatitis B	0.000934	0.00401	CcSEcCtD
Ezetimibe—Skin disorder—Telbivudine—hepatitis B	0.000933	0.00401	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000933	0.00401	CcSEcCtD
Ezetimibe—Body temperature increased—Entecavir—hepatitis B	0.000925	0.00397	CcSEcCtD
Ezetimibe—Abdominal pain—Entecavir—hepatitis B	0.000925	0.00397	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—GGT2—hepatitis B	0.000916	0.0136	CbGpPWpGaD
Ezetimibe—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000902	0.00388	CcSEcCtD
Ezetimibe—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000902	0.00388	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000875	0.00376	CcSEcCtD
Ezetimibe—Insomnia—Telbivudine—hepatitis B	0.000869	0.00373	CcSEcCtD
Ezetimibe—Paraesthesia—Telbivudine—hepatitis B	0.000863	0.00371	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00086	0.0128	CbGpPWpGaD
Ezetimibe—Dyspepsia—Telbivudine—hepatitis B	0.000846	0.00363	CcSEcCtD
Ezetimibe—Asthenia—Entecavir—hepatitis B	0.000839	0.00361	CcSEcCtD
Ezetimibe—UGT1A3—Phase II conjugation—GGT2—hepatitis B	0.000839	0.0125	CbGpPWpGaD
Ezetimibe—Neuropathy peripheral—Lamivudine—hepatitis B	0.000832	0.00358	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00083	0.00356	CcSEcCtD
Ezetimibe—Fatigue—Telbivudine—hepatitis B	0.000828	0.00356	CcSEcCtD
Ezetimibe—Jaundice—Lamivudine—hepatitis B	0.000828	0.00356	CcSEcCtD
Ezetimibe—Pain—Telbivudine—hepatitis B	0.000822	0.00353	CcSEcCtD
Ezetimibe—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000819	0.00352	CcSEcCtD
Ezetimibe—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000807	0.00347	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Lamivudine—hepatitis B	0.000803	0.00345	CcSEcCtD
Ezetimibe—Diarrhoea—Entecavir—hepatitis B	0.0008	0.00344	CcSEcCtD
Ezetimibe—Sinusitis—Lamivudine—hepatitis B	0.000797	0.00342	CcSEcCtD
Ezetimibe—Feeling abnormal—Telbivudine—hepatitis B	0.000792	0.0034	CcSEcCtD
Ezetimibe—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000789	0.0117	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Telbivudine—hepatitis B	0.000786	0.00338	CcSEcCtD
Ezetimibe—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000781	0.00336	CcSEcCtD
Ezetimibe—Dizziness—Entecavir—hepatitis B	0.000773	0.00332	CcSEcCtD
Ezetimibe—ABCC2—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00077	0.0115	CbGpPWpGaD
Ezetimibe—Hepatitis—Lamivudine—hepatitis B	0.000762	0.00328	CcSEcCtD
Ezetimibe—ABCC2—liver—hepatitis B	0.00076	0.00541	CbGeAlD
Ezetimibe—Abdominal pain—Telbivudine—hepatitis B	0.00076	0.00326	CcSEcCtD
Ezetimibe—Body temperature increased—Telbivudine—hepatitis B	0.00076	0.00326	CcSEcCtD
Ezetimibe—Pharyngitis—Lamivudine—hepatitis B	0.000756	0.00325	CcSEcCtD
Ezetimibe—Connective tissue disorder—Lamivudine—hepatitis B	0.000749	0.00322	CcSEcCtD
Ezetimibe—Vomiting—Entecavir—hepatitis B	0.000744	0.0032	CcSEcCtD
Ezetimibe—UGT2B15—Phase II conjugation—GGT1—hepatitis B	0.000741	0.011	CbGpPWpGaD
Ezetimibe—Rash—Entecavir—hepatitis B	0.000737	0.00317	CcSEcCtD
Ezetimibe—Dermatitis—Entecavir—hepatitis B	0.000737	0.00317	CcSEcCtD
Ezetimibe—Headache—Entecavir—hepatitis B	0.000733	0.00315	CcSEcCtD
Ezetimibe—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000726	0.00312	CcSEcCtD
Ezetimibe—Erythema multiforme—Lamivudine—hepatitis B	0.000721	0.0031	CcSEcCtD
Ezetimibe—Rash—Adefovir Dipivoxil—hepatitis B	0.00072	0.00309	CcSEcCtD
Ezetimibe—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000719	0.00309	CcSEcCtD
Ezetimibe—Headache—Adefovir Dipivoxil—hepatitis B	0.000715	0.00307	CcSEcCtD
Ezetimibe—UGT2B7—Phase II conjugation—GGT2—hepatitis B	0.000713	0.0106	CbGpPWpGaD
Ezetimibe—ABCG2—blood—hepatitis B	0.000709	0.00505	CbGeAlD
Ezetimibe—SLCO1B1—Transport of organic anions—ALB—hepatitis B	0.000705	0.0105	CbGpPWpGaD
Ezetimibe—ABCC3—Recycling of bile acids and salts—ALB—hepatitis B	0.000702	0.0104	CbGpPWpGaD
Ezetimibe—Nausea—Entecavir—hepatitis B	0.000695	0.00299	CcSEcCtD
Ezetimibe—Asthenia—Telbivudine—hepatitis B	0.000689	0.00296	CcSEcCtD
Ezetimibe—Immune system disorder—Lamivudine—hepatitis B	0.000688	0.00296	CcSEcCtD
Ezetimibe—Mediastinal disorder—Lamivudine—hepatitis B	0.000687	0.00295	CcSEcCtD
Ezetimibe—Pruritus—Telbivudine—hepatitis B	0.00068	0.00292	CcSEcCtD
Ezetimibe—Nausea—Adefovir Dipivoxil—hepatitis B	0.000678	0.00291	CcSEcCtD
Ezetimibe—Alopecia—Lamivudine—hepatitis B	0.000674	0.00289	CcSEcCtD
Ezetimibe—Malnutrition—Lamivudine—hepatitis B	0.000663	0.00285	CcSEcCtD
Ezetimibe—Erythema—Lamivudine—hepatitis B	0.000663	0.00285	CcSEcCtD
Ezetimibe—Diarrhoea—Telbivudine—hepatitis B	0.000657	0.00283	CcSEcCtD
Ezetimibe—Flatulence—Lamivudine—hepatitis B	0.000654	0.00281	CcSEcCtD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000653	0.00972	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000652	0.0097	CbGpPWpGaD
Ezetimibe—Back pain—Lamivudine—hepatitis B	0.000642	0.00276	CcSEcCtD
Ezetimibe—Muscle spasms—Lamivudine—hepatitis B	0.000638	0.00274	CcSEcCtD
Ezetimibe—Dizziness—Telbivudine—hepatitis B	0.000635	0.00273	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN2A—hepatitis B	0.000632	0.0094	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000627	0.00933	CbGpPWpGaD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—TGFB1—hepatitis B	0.000617	0.00919	CbGpPWpGaD
Ezetimibe—Ill-defined disorder—Lamivudine—hepatitis B	0.000616	0.00265	CcSEcCtD
Ezetimibe—Anaemia—Lamivudine—hepatitis B	0.000613	0.00264	CcSEcCtD
Ezetimibe—Vomiting—Telbivudine—hepatitis B	0.000611	0.00263	CcSEcCtD
Ezetimibe—Angioedema—Lamivudine—hepatitis B	0.000606	0.00261	CcSEcCtD
Ezetimibe—Rash—Telbivudine—hepatitis B	0.000606	0.0026	CcSEcCtD
Ezetimibe—Dermatitis—Telbivudine—hepatitis B	0.000605	0.0026	CcSEcCtD
Ezetimibe—Headache—Telbivudine—hepatitis B	0.000602	0.00259	CcSEcCtD
Ezetimibe—Malaise—Lamivudine—hepatitis B	0.000598	0.00257	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—CD4—hepatitis B	0.000595	0.00885	CbGpPWpGaD
Ezetimibe—UGT1A1—Phase II conjugation—GGT2—hepatitis B	0.00058	0.00863	CbGpPWpGaD
Ezetimibe—Cough—Lamivudine—hepatitis B	0.000579	0.00249	CcSEcCtD
Ezetimibe—Nausea—Telbivudine—hepatitis B	0.000571	0.00245	CcSEcCtD
Ezetimibe—Arthralgia—Lamivudine—hepatitis B	0.000565	0.00243	CcSEcCtD
Ezetimibe—Chest pain—Lamivudine—hepatitis B	0.000565	0.00243	CcSEcCtD
Ezetimibe—Myalgia—Lamivudine—hepatitis B	0.000565	0.00243	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000561	0.00241	CcSEcCtD
Ezetimibe—UGT1A3—NRF2 pathway—GGT2—hepatitis B	0.00056	0.00833	CbGpPWpGaD
Ezetimibe—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000559	0.00831	CbGpPWpGaD
Ezetimibe—Discomfort—Lamivudine—hepatitis B	0.000558	0.0024	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—CYP2A6—hepatitis B	0.000555	0.00826	CbGpPWpGaD
Ezetimibe—ABCG2—liver—hepatitis B	0.000555	0.00395	CbGeAlD
Ezetimibe—Dry mouth—Lamivudine—hepatitis B	0.000552	0.00237	CcSEcCtD
Ezetimibe—Confusional state—Lamivudine—hepatitis B	0.000546	0.00235	CcSEcCtD
Ezetimibe—Anaphylactic shock—Lamivudine—hepatitis B	0.000541	0.00233	CcSEcCtD
Ezetimibe—Infection—Lamivudine—hepatitis B	0.000538	0.00231	CcSEcCtD
Ezetimibe—Nervous system disorder—Lamivudine—hepatitis B	0.000531	0.00228	CcSEcCtD
Ezetimibe—Thrombocytopenia—Lamivudine—hepatitis B	0.00053	0.00228	CcSEcCtD
Ezetimibe—Skin disorder—Lamivudine—hepatitis B	0.000526	0.00226	CcSEcCtD
Ezetimibe—ANPEP—Peptide hormone metabolism—CTNNB1—hepatitis B	0.000524	0.00779	CbGpPWpGaD
Ezetimibe—SLCO1B1—Recycling of bile acids and salts—ALB—hepatitis B	0.000523	0.00778	CbGpPWpGaD
Ezetimibe—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000519	0.00773	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN1A—hepatitis B	0.000516	0.00768	CbGpPWpGaD
Ezetimibe—UGT1A3—Metapathway biotransformation—AKR1B1—hepatitis B	0.000505	0.00751	CbGpPWpGaD
Ezetimibe—CYP3A4—blood—hepatitis B	0.000494	0.00352	CbGeAlD
Ezetimibe—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000493	0.00212	CcSEcCtD
Ezetimibe—UGT1A3—Biological oxidations—GGT2—hepatitis B	0.000491	0.0073	CbGpPWpGaD
Ezetimibe—Insomnia—Lamivudine—hepatitis B	0.00049	0.0021	CcSEcCtD
Ezetimibe—Paraesthesia—Lamivudine—hepatitis B	0.000486	0.00209	CcSEcCtD
Ezetimibe—Dyspnoea—Lamivudine—hepatitis B	0.000483	0.00207	CcSEcCtD
Ezetimibe—Dyspepsia—Lamivudine—hepatitis B	0.000477	0.00205	CcSEcCtD
Ezetimibe—ABCC3—NRF2 pathway—GGT2—hepatitis B	0.000476	0.00708	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—GGT2—hepatitis B	0.000476	0.00708	CbGpPWpGaD
Ezetimibe—Decreased appetite—Lamivudine—hepatitis B	0.000471	0.00202	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000467	0.00201	CcSEcCtD
Ezetimibe—Fatigue—Lamivudine—hepatitis B	0.000467	0.00201	CcSEcCtD
Ezetimibe—Pain—Lamivudine—hepatitis B	0.000463	0.00199	CcSEcCtD
Ezetimibe—Constipation—Lamivudine—hepatitis B	0.000463	0.00199	CcSEcCtD
Ezetimibe—Feeling abnormal—Lamivudine—hepatitis B	0.000446	0.00192	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Lamivudine—hepatitis B	0.000443	0.0019	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—GGT1—hepatitis B	0.000433	0.00645	CbGpPWpGaD
Ezetimibe—Urticaria—Lamivudine—hepatitis B	0.00043	0.00185	CcSEcCtD
Ezetimibe—UGT2B7—Metapathway biotransformation—AKR1B1—hepatitis B	0.000429	0.00639	CbGpPWpGaD
Ezetimibe—Body temperature increased—Lamivudine—hepatitis B	0.000428	0.00184	CcSEcCtD
Ezetimibe—Abdominal pain—Lamivudine—hepatitis B	0.000428	0.00184	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—GGT2—hepatitis B	0.000417	0.00621	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000399	0.00594	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Lamivudine—hepatitis B	0.000399	0.00171	CcSEcCtD
Ezetimibe—UGT1A3—Phase II conjugation—GGT1—hepatitis B	0.000397	0.00591	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00039	0.0058	CbGpPWpGaD
Ezetimibe—Asthenia—Lamivudine—hepatitis B	0.000389	0.00167	CcSEcCtD
Ezetimibe—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000388	0.00578	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GGT2—hepatitis B	0.000387	0.00575	CbGpPWpGaD
Ezetimibe—CYP3A4—liver—hepatitis B	0.000386	0.00275	CbGeAlD
Ezetimibe—Pruritus—Lamivudine—hepatitis B	0.000383	0.00165	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—AKR1B1—hepatitis B	0.000383	0.0057	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—GGT2—hepatitis B	0.000377	0.00561	CbGpPWpGaD
Ezetimibe—Diarrhoea—Lamivudine—hepatitis B	0.00037	0.00159	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—GGT2—hepatitis B	0.000367	0.00546	CbGpPWpGaD
Ezetimibe—ABCC3—Bile acid and bile salt metabolism—ALB—hepatitis B	0.000367	0.00546	CbGpPWpGaD
Ezetimibe—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000362	0.00539	CbGpPWpGaD
Ezetimibe—Dizziness—Lamivudine—hepatitis B	0.000358	0.00154	CcSEcCtD
Ezetimibe—ABCB1—blood—hepatitis B	0.00035	0.00249	CbGeAlD
Ezetimibe—UGT1A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000349	0.00519	CbGpPWpGaD
Ezetimibe—Vomiting—Lamivudine—hepatitis B	0.000344	0.00148	CcSEcCtD
Ezetimibe—Rash—Lamivudine—hepatitis B	0.000341	0.00147	CcSEcCtD
Ezetimibe—Dermatitis—Lamivudine—hepatitis B	0.000341	0.00147	CcSEcCtD
Ezetimibe—Headache—Lamivudine—hepatitis B	0.000339	0.00146	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—GGT2—hepatitis B	0.000339	0.00505	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—CYP2A6—hepatitis B	0.000339	0.00505	CbGpPWpGaD
Ezetimibe—UGT2B7—Phase II conjugation—GGT1—hepatitis B	0.000337	0.00502	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000334	0.00498	CbGpPWpGaD
Ezetimibe—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000325	0.00483	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000324	0.00482	CbGpPWpGaD
Ezetimibe—Nausea—Lamivudine—hepatitis B	0.000322	0.00138	CcSEcCtD
Ezetimibe—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000312	0.00465	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—CYP2A6—hepatitis B	0.000297	0.00443	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000296	0.0044	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKR1B1—hepatitis B	0.00029	0.00432	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—CYP2A6—hepatitis B	0.000288	0.00429	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—CYP2A6—hepatitis B	0.000288	0.00429	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000288	0.00428	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000284	0.00423	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—HSPA5—hepatitis B	0.000281	0.00419	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKR1B1—hepatitis B	0.000279	0.00416	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GGT2—hepatitis B	0.000278	0.00414	CbGpPWpGaD
Ezetimibe—UGT1A1—Phase II conjugation—GGT1—hepatitis B	0.000274	0.00408	CbGpPWpGaD
Ezetimibe—ABCB1—liver—hepatitis B	0.000273	0.00195	CbGeAlD
Ezetimibe—SLCO1B1—Bile acid and bile salt metabolism—ALB—hepatitis B	0.000273	0.00407	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GGT2—hepatitis B	0.000268	0.00399	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—GGT1—hepatitis B	0.000265	0.00394	CbGpPWpGaD
Ezetimibe—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000264	0.00393	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000262	0.00389	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—CYP2A6—hepatitis B	0.000253	0.00376	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—CYP2A6—hepatitis B	0.000234	0.00349	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—GGT1—hepatitis B	0.000232	0.00345	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—CYP2A6—hepatitis B	0.000229	0.0034	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—GGT1—hepatitis B	0.000225	0.00335	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—GGT1—hepatitis B	0.000225	0.00335	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000224	0.00334	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000224	0.00333	CbGpPWpGaD
Ezetimibe—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000223	0.00332	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CYP2A6—hepatitis B	0.000222	0.00331	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000216	0.00321	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00021	0.00312	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000207	0.00309	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—CYP2A6—hepatitis B	0.000205	0.00306	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—hepatitis B	0.000205	0.00305	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GOT2—hepatitis B	0.000201	0.00299	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000199	0.00296	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—GGT1—hepatitis B	0.000197	0.00294	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000185	0.00276	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GGT1—hepatitis B	0.000183	0.00272	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—GGT1—hepatitis B	0.000178	0.00266	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GOT1—hepatitis B	0.000174	0.00258	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GGT1—hepatitis B	0.000174	0.00258	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CYP2A6—hepatitis B	0.000169	0.00251	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000167	0.00249	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKR1B1—hepatitis B	0.000163	0.00243	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CYP2A6—hepatitis B	0.000162	0.00241	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—GGT1—hepatitis B	0.00016	0.00239	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000158	0.00235	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000157	0.00234	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GGT2—hepatitis B	0.000157	0.00233	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000155	0.00231	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000154	0.00228	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GOT2—hepatitis B	0.000152	0.00227	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—F2—hepatitis B	0.000152	0.00226	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000151	0.00225	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ALB—hepatitis B	0.000149	0.00222	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GOT2—hepatitis B	0.000147	0.00218	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000145	0.00215	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ALB—hepatitis B	0.000144	0.00214	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—hepatitis B	0.000141	0.0021	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000135	0.00201	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000133	0.00198	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GGT1—hepatitis B	0.000132	0.00196	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GOT1—hepatitis B	0.000132	0.00196	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GOT1—hepatitis B	0.000127	0.00189	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GGT1—hepatitis B	0.000127	0.00189	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000124	0.00185	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.00012	0.00178	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000115	0.00172	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000113	0.00168	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000113	0.00168	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000109	0.00163	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000105	0.00157	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000101	0.00151	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.0001	0.00149	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-A—hepatitis B	9.98e-05	0.00148	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—CTNNB1—hepatitis B	9.88e-05	0.00147	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	9.86e-05	0.00147	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GGT2—hepatitis B	9.59e-05	0.00143	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP2A6—hepatitis B	9.5e-05	0.00141	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ALB—hepatitis B	9.24e-05	0.00137	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	9.22e-05	0.00137	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	9.11e-05	0.00136	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—TGFB1—hepatitis B	8.91e-05	0.00133	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKR1B1—hepatitis B	8.76e-05	0.0013	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GOT2—hepatitis B	8.59e-05	0.00128	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GGT2—hepatitis B	8.4e-05	0.00125	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.58e-05	0.00113	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—TGFB1—hepatitis B	7.57e-05	0.00113	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFB1—hepatitis B	7.57e-05	0.00113	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKR1B1—hepatitis B	7.45e-05	0.00111	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKR1B1—hepatitis B	7.45e-05	0.00111	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GOT1—hepatitis B	7.41e-05	0.0011	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GGT1—hepatitis B	7.41e-05	0.0011	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GGT2—hepatitis B	7.14e-05	0.00106	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GGT2—hepatitis B	7.14e-05	0.00106	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTEN—hepatitis B	7.05e-05	0.00105	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ALB—hepatitis B	7e-05	0.00104	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ALB—hepatitis B	6.74e-05	0.001	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IFNG—hepatitis B	6.66e-05	0.00099	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—TGFB1—hepatitis B	6.15e-05	0.000916	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKR1B1—hepatitis B	6.05e-05	0.0009	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFB1—hepatitis B	6e-05	0.000893	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—hepatitis B	5.92e-05	0.00088	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	5.81e-05	0.000864	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GGT2—hepatitis B	5.8e-05	0.000863	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.65e-05	0.00084	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—ALB—hepatitis B	5.62e-05	0.000836	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKR1B1—hepatitis B	5.54e-05	0.000825	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTEN—hepatitis B	5.34e-05	0.000795	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GGT2—hepatitis B	5.32e-05	0.000791	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	5.19e-05	0.000773	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTEN—hepatitis B	5.14e-05	0.000765	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKR1B1—hepatitis B	5.13e-05	0.000764	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP2A6—hepatitis B	5.09e-05	0.000757	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	5.01e-05	0.000745	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GGT2—hepatitis B	4.92e-05	0.000732	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TGFB1—hepatitis B	4.61e-05	0.000687	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GOT2—hepatitis B	4.6e-05	0.000684	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GGT1—hepatitis B	4.53e-05	0.000675	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP2A6—hepatitis B	4.32e-05	0.000644	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP2A6—hepatitis B	4.32e-05	0.000644	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—hepatitis B	4.31e-05	0.000641	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.03e-05	0.0006	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GOT1—hepatitis B	3.97e-05	0.000591	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GGT1—hepatitis B	3.97e-05	0.000591	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—hepatitis B	3.94e-05	0.000587	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GOT2—hepatitis B	3.91e-05	0.000582	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GOT2—hepatitis B	3.91e-05	0.000582	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—hepatitis B	3.83e-05	0.000571	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2A6—hepatitis B	3.51e-05	0.000523	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GGT1—hepatitis B	3.38e-05	0.000502	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GOT1—hepatitis B	3.38e-05	0.000502	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GGT1—hepatitis B	3.38e-05	0.000502	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GOT1—hepatitis B	3.38e-05	0.000502	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2A6—hepatitis B	3.22e-05	0.000479	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GOT2—hepatitis B	3.18e-05	0.000473	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.08e-05	0.000458	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—hepatitis B	3.04e-05	0.000452	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTEN—hepatitis B	3.01e-05	0.000448	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3e-05	0.000447	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2A6—hepatitis B	2.98e-05	0.000444	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GOT2—hepatitis B	2.91e-05	0.000433	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—hepatitis B	2.86e-05	0.000425	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	2.82e-05	0.000419	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKR1B1—hepatitis B	2.78e-05	0.000413	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	2.75e-05	0.00041	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	2.75e-05	0.000409	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GGT1—hepatitis B	2.74e-05	0.000408	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GOT1—hepatitis B	2.74e-05	0.000408	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	2.73e-05	0.000407	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GOT2—hepatitis B	2.7e-05	0.000401	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GGT2—hepatitis B	2.66e-05	0.000396	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	2.64e-05	0.000393	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GOT1—hepatitis B	2.51e-05	0.000374	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GGT1—hepatitis B	2.51e-05	0.000374	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GGT1—hepatitis B	2.33e-05	0.000346	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GOT1—hepatitis B	2.33e-05	0.000346	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.29e-05	0.000341	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.28e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.13e-05	0.000316	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—hepatitis B	2.11e-05	0.000314	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.87e-05	0.000279	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—hepatitis B	1.8e-05	0.000267	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—hepatitis B	1.8e-05	0.000267	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.71e-05	0.000254	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GGT2—hepatitis B	1.64e-05	0.000244	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2A6—hepatitis B	1.61e-05	0.00024	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—hepatitis B	1.61e-05	0.00024	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—hepatitis B	1.46e-05	0.000217	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GOT2—hepatitis B	1.46e-05	0.000217	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.43e-05	0.000213	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—hepatitis B	1.37e-05	0.000204	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—hepatitis B	1.37e-05	0.000204	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—hepatitis B	1.34e-05	0.000199	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GOT1—hepatitis B	1.26e-05	0.000187	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GGT1—hepatitis B	1.26e-05	0.000187	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—hepatitis B	1.24e-05	0.000184	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—hepatitis B	1.11e-05	0.000166	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—hepatitis B	1.02e-05	0.000152	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2A6—hepatitis B	9.93e-06	0.000148	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—hepatitis B	9.45e-06	0.000141	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GOT2—hepatitis B	8.98e-06	0.000134	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GGT1—hepatitis B	7.75e-06	0.000115	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GOT1—hepatitis B	7.75e-06	0.000115	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—hepatitis B	6.69e-06	9.96e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—hepatitis B	5.11e-06	7.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—hepatitis B	4.12e-06	6.14e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—hepatitis B	3.15e-06	4.68e-05	CbGpPWpGaD
